Source:http://linkedlifedata.com/resource/pubmed/id/15075625
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-4-12
|
pubmed:abstractText |
The effect of the non-selective 5-HT2C receptor agonist trifluoromethyl-phenylpiperazine (TFMPP, 0.75, 1.5 and 3.0 microg) and the preferential 5-HT2C agonist 6-chloro-2(1-piperazinyl)pyrazine (MK-212, 0.1, 0.3 and 1.0 microg) microinjected into the ventral or dorsal hippocampus was investigated in anxiety measures of rats exposed to the elevated plus-maze test. Ventral hippocampal (VH) microinjections of the 0.75 or 1.5 microg doses of TFMPP reduced open-arm exploration without affecting the number of closed-arm entries, indicating a selective anxiogenic profile. The highest dose (3.0 microg) reduced open- and closed-arm entries, suggesting interference in locomotor activity. The 0.1 microg dose of MK-212 also caused a selective anxiogenic effect when microinjected into the ventral hippocampus, without disturbing locomotor activity. Microinjections of the two higher doses of MK-212 (0.3 or 1.0 microg) into the ventral hippocampus led to a decrease of exploration in both arms of the maze. In contrast to the anxiogenic effect observed in the VH, neither TFMPP nor MK-212 significantly changed anxiety measures when microinjected into the dorsal hippocampus. These results suggest that activation of 5-HT2C postsynaptic receptors located in the ventral, but not in the dorsal, hippocampus play an important role in anxiety triggered by the elevated plus-maze test.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-(3-trifluoromethylphenyl)piperazin...,
http://linkedlifedata.com/resource/pubmed/chemical/MK 212,
http://linkedlifedata.com/resource/pubmed/chemical/Piperazines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin 5-HT2 Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Receptor Agonists
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0955-8810
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37-43
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15075625-Animals,
pubmed-meshheading:15075625-Arousal,
pubmed-meshheading:15075625-Brain Mapping,
pubmed-meshheading:15075625-Dose-Response Relationship, Drug,
pubmed-meshheading:15075625-Fear,
pubmed-meshheading:15075625-Hippocampus,
pubmed-meshheading:15075625-Male,
pubmed-meshheading:15075625-Maze Learning,
pubmed-meshheading:15075625-Microinjections,
pubmed-meshheading:15075625-Piperazines,
pubmed-meshheading:15075625-Pyrazines,
pubmed-meshheading:15075625-Rats,
pubmed-meshheading:15075625-Rats, Wistar,
pubmed-meshheading:15075625-Serotonin 5-HT2 Receptor Agonists,
pubmed-meshheading:15075625-Serotonin Receptor Agonists
|
pubmed:year |
2004
|
pubmed:articleTitle |
Anxiogenic effects in the rat elevated plus-maze of 5-HT(2C) agonists into ventral but not dorsal hippocampus.
|
pubmed:affiliation |
Departamento de Processos Psicológicos Básicos, Instituto de Psicologia, Universidade de Brasília, Brasília, Brazil.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|